Supplemental material
OncoImmunology
Volume 8, 2019 - Issue 11
Open access
1,655
Views
6
CrossRef citations to date
0
Altmetric
Original Research
Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo
Noémie JoallandCRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes, Nantes, France;LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceCorrespondence[email protected]
View further author information
, View further author information
Laura LafranceCRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes, Nantes, France;LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceView further author information
, Thibauld OullierCancéropôle du Grand Ouest, Plateforme In Vivo, Nantes, FranceView further author information
, Séverine Marionneau-LambotCancéropôle du Grand Ouest, Plateforme In Vivo, Nantes, FranceView further author information
, Delphine LoussouarnCRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes, Nantes, France;Centre Hospitalier-Universitaire (CHU) de Nantes, Nantes, FranceView further author information
, Ulrich JarryCRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes, Nantes, France;LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceView further author information
& Emmanuel ScotetCRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes, Nantes, France;LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceView further author information
show all
Article: e1649971
|
Received 25 Feb 2019, Accepted 25 Jul 2019, Published online: 28 Aug 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.